FDA Inspection 1134216 — James A. Welker, DO

James A. Welker, DO — FEI 3013109501

The FDA completed an inspection of James A. Welker, DO on Nov 20, 2020 in Annapolis, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Nov 20, 2020
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Annapolis, MD (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.